SCHEMBL25017019

SCHEMBL25017019

O=CCCCCCOc1ccc2c(c1)CCc1c3c(c4c(c1-2)-c1ccc(O)cc1CC4)C(=O)N(c1ccccc1)C3=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.38
ITGA2B P08514 6/20 0.38
ESR1 P03372 2/20 0.38
AOC3 Q16853 2/20 0.37
MAOB P27338 3/20 0.36
MIF P14174 2/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
MAOA P21397 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ESR2 Q92731 1/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016866 0.94 ITGB3 (0.40) ITGB3ITGA2BAOC3MAOBMAOA
SCHEMBL22703066 0.89 ITGB3 (0.36) ITGB3ITGA2BAOC3MAOBMAOA
SCHEMBL25018113 0.86 BRD4 (0.45) ITGB3ITGA2BAOC3MAOBMAOA
SCHEMBL25017621 0.81 ESR1 (0.56) ESR1MAOBMIFKDM4EPOLB
SCHEMBL22703031 0.81 ESR1 (0.50) ESR1MIFKDM4EPOLBMEN1
SCHEMBL22683257 0.79 MAOB (0.39) ITGB3ITGA2BMAOBMIFMAOA
SCHEMBL25017625 0.79 BRD4 (0.50) ITGB3ITGA2BMAOBMAOA
SCHEMBL22703030 0.76 MIF (0.41) ESR1AOC3MAOBMIFMAOA
SCHEMBL25016874 0.75 ESR1 (0.36) ESR1MAOBPOLBMAOAHRH3
SCHEMBL20031893 0.74 GAA (0.46) MIFKDM4EPOLBMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578040-B2 [5]Helicene derivatives as molecular reporters for diagnostic applications and methods of synthesis therefor NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (TH) 2023-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578040-B2 [5]Helicene derivatives as molecular reporters for diagnostic applications and methods of synthesis therefor OR51E2, HDHD5, WEE1 ITGB3 4056/4885ITGA2B 4112/4885ESR1 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.